GlassScriptPhysician profile
Ruben A Hernandez
NPI 1700879897
$18,192.27
in general payments reported to CMS, 2019-2025
64 companies · $3,388 in 2025
The $3,388 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,478 · 2020: $1,531 · 2021: $2,396 · 2022: $2,317 · 2023: $2,979 · 2024: $3,103 · 2025: $3,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,469.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,907.17 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,857.55 | 2019-2025 | Jardiance, Tradjenta, Stiolto Respimat |
| Glaxosmithkline, LLC. | $1,841.41 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,186.15 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $1,046.30 | 2019-2025 | Verquvo, Belsomra, Capvaxive |
| Lilly USA, LLC | $1,037.32 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $924.14 | 2019-2025 | Repatha, Otezla, Prolia |
| Abbvie INC. | $846.96 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $754.23 | 2021-2025 | Rexulti, Abilify Asimtufii |
| Dexcom, INC. | $677.63 | 2021-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $654.84 | 2021-2025 | |
| Pfizer INC. | $522.86 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $467.59 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $375.04 | 2019-2023 | |
| Ironwood Pharmaceuticals, INC | $335.38 | 2019-2024 | Linzess |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $273.49 | 2021-2025 | Id Now Instrument, Freestyle Libre 2, Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $237.89 | 2024-2025 | Gemtesa |
| Allergan, INC. | $217.72 | 2019-2020 | |
| Lundbeck LLC | $166.56 | 2022-2025 | Rexulti |
| Alnylam Pharmaceuticals INC. | $166.15 | 2023-2024 | Amvuttra, Onpattro |
| Phathom Pharmaceuticals, INC. | $158.82 | 2024-2025 | Voquezna |
| Mylan Specialty L.P. | $150.87 | 2023-2024 | Yupelri |
| Gilead Sciences, INC. | $142.40 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $140.38 | 2023 | Austedo Xr, Ajovy |
| Regeneron Healthcare Solutions, INC. | $138.25 | 2024-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $131.77 | 2019-2020 | |
| Astellas Pharma US INC | $127.70 | 2019-2024 | Veozah |
| Xeris Pharmaceuticals, INC. | $115.41 | 2020-2025 | Gvoke Hypopen |
| Optinose US, INC. | $104.90 | 2019-2022 | |
| Exact Sciences Corporation | $99.98 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Radius Health, INC. | $93.08 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $91.35 | 2021 | |
| Depuy Synthes Sales INC. | $88.52 | 2022-2023 | Orthovisc, Monovisc |
| Arbor Pharmaceuticals, INC. | $87.85 | 2019-2021 | |
| Amarin Pharma, INC. | $82.75 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $75.97 | 2021-2023 | |
| Philips North America LLC | $69.85 | 2019-2021 | |
| Viatris Specialty LLC | $58.98 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $56.47 | 2021-2024 | Eliquis |
| Sanofi Pasteur INC. | $54.74 | 2019-2025 | |
| Daiichi Sankyo INC. | $48.24 | 2020-2021 | |
| Ardelyx, INC. | $47.93 | 2024 | Ibsrela |
| Bioventus LLC | $42.89 | 2022-2023 | Supartz Fx Sodium Hyaluronate |
| Sunovion Pharmaceuticals INC. | $42.41 | 2019 | |
| Madrigal Pharmaceuticals | $36.22 | 2024-2025 | Rezdiffra, Resmetirom |
| Ibsa Pharma INC. | $33.06 | 2020 | |
| Abiomed | $31.01 | 2025 | |
| Globus Medical, INC. | $28.11 | 2025 | Senza |
| Hologic Sales and Service, LLC | $25.98 | 2019 | |
| Corium, LLC | $25.53 | 2023 | Adlarity |
| Corcept Therapeutics | $24.72 | 2021 | |
| Ascensia Diabetes Care US INC. | $22.98 | 2025 | |
| Verona Pharma, INC. | $22.66 | 2025 | Ohtuvayre |
| Tandem Diabetes Care, INC. | $22.12 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Zimmer Biomet Holdings, INC. | $22.07 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Redhill Biopharma INC. | $21.66 | 2020 | |
| Stryker Corporation | $20.45 | 2023 | Insignia |
| Phadia US INC. | $19.97 | 2024 | Immunocap |
| Esperion Therapeutics, INC. | $17.41 | 2021 | |
| Medtronic Minimed, INC. | $16.82 | 2020 | |
| Horizon Therapeutics Plc | $14.40 | 2022 | |
| Medtronic, INC. | $14.33 | 2021 | |
| Vertiflex, INC. | $14.05 | 2019 | |
| Therapeuticsmd, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.